JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo RIUMAComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentrosEsta colecciónPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentros

    Mi cuenta

    AccederRegistro

    DE INTERÉS

    Datos de investigaciónPolítica institucional UMAPolítica de RIUMAPolitica de datos de investigación en RIUMASHERPA/RoMEODulcinea
    Preguntas frecuentesManual de usoDerechos de autorContacto/Sugerencias
    Listar FP - Artículos por título 
    •   RIUMA Principal
    • Investigación
    • Farmacología y Pediatría - (FP)
    • FP - Artículos
    • Listar FP - Artículos por título
    •   RIUMA Principal
    • Investigación
    • Farmacología y Pediatría - (FP)
    • FP - Artículos
    • Listar FP - Artículos por título

    Listar FP - Artículos por título

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    Ordenar por:

    Orden:

    Resultados:

    Mostrando ítems 7-13 de 13

    • título
    • fecha de publicación
    • fecha de envío
    • ascendente
    • descendente
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry 

        Sanabria Cabrera, Judith Adriana; Sanjuán-Jimenéz, Rocío; Clavijo-Frutos, Encarnacion; Medina-Cáliz, Inmaculada; González-Jiménez, Andrés; [et al.] (2020)
        Background and Aims: Drug-induced liver injury (DILI) presents with a wide phenotypic spectrum requiring an extensive differential diagnosis. Hepatitis E virus (HEV) is not systematically ruled out during acute hepatitis ...
      • Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study 

        Cueto-Sanchez, Alejandro; Niu, Hao; Del Campo-Herrera, Enrique; Robles-Diaz, Mercedes; Sanabria-Cabrera, Judith; [et al.] (Wiley, 2021-09-20)
        The identification of specific HLA risk alleles in drug-induced liver injury (DILI) points toward an important role of the adaptive immune system in DILI development. In this study, we aimed to corroborate the role of an ...
      • Neuroprotective Effect of 3′,4′-Dihydroxyphenylglycol in Type-1-like Diabetic Rats—Influence of the Hydroxytyrosol/3′,4′-dihydroxyphenylglycol Ratio 

        Rodríguez Pérez, María Dolores; Pérez de Algaba, Inmaculada; Martín Aurioles, Esther; Ortega-Hombrados, Laura; Verdugo, Cristina; [et al.] (IOAP-MPDI, 2022-03-08)
        The aim of this study was to assess the possible neuroprotective effect of 3′,4′-dihydroxyphenylglycol (DHPG), a polyphenol from extra virgin olive oil (EVOO), in an experimental model of diabetes and whether this effect ...
      • Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice 

        Villanueva-Paz, Marina; Morán, Laura; Lopez-Alcantara, Nuria; Freixo, Cristiana; Andrade-Bellido, Raul Jesus; [et al.] (MDPI, 2021-03-05)
        Idiosyncratic drug-induced liver injury (DILI) is a type of hepatic injury caused by an uncommon drug adverse reaction that can develop to conditions spanning from asymptomatic liver laboratoryabnormalitiestoacuteliverfa ...
      • Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction 

        Segovia-Zafra, Antonio; Di Zeo-Sánchez, Daniel Enrique; López-Gómez, Carlos; Pérez-Valdés, Zeus; García-Fuentes, Eduardo; [et al.] (Elsevier, 2021-12)
        Idiosyncratic drug-induced liver injury (iDILI) encompasses the unexpected harms that pre- scription and non-prescription drugs, herbal and dietary supplements can cause to the liver. iDILI remains a major public health ...
      • Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials 

        Niu, Hao; Sanabria-Cabrera, Judith; Alvarez-Alvarez, Ismael; Robles-Diaz, Mercedes; Stankeviciute, Simona; [et al.] (Elsevier, 2021-02)
        Conducting randomised clinical trials (RCTs) in idiosyncratic drug-induced liver injury (DILI) is challenging. This systematic review aims to summarise the design and findings of RCTs in the prevention and management of ...
      • Serious liver injury induced by Nimesulide: an international collaboration study reporting 57 cases 

        Bessone, Fernando; Hernandez, Nelia; Mendizabal, Manuel; Ridruejo, Ezequiel; Gualano, Gisela; [et al.] (Springer, 2021-03-24)
        Nimesulide is a non-steroidal anti-inflammatory drug still marketed in many countries. We aim to analyze the clinical phenotype, outcome, and histological features of nimesulide-induced liver injury (nimesulide-DILI). We ...
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
         

         

        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
        REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA